|
|
Regency A
| |||
P4: PL4 - Viral Hepatitis Prevention for IDU: What is it and What Should We be Doing? | |||
| While Injection Drug Users (IDU) prevention efforts have been focused on HIV and politicized by syringe exchange, basic questions remain about effective viral hepatitis prevention and control interventions. This plenary will review epidemiologic, scientific and programmatic aspects of viral hepatitis prevention in IDU including hepatitis C epidemiology, a framework and the underlying science for considering prevention strategies, and the components of a comprehensive prevention strategy with examples of how they are being implemented. | |||
| Learning Objectives: A. Outline strategies for hepatitis prevention for infants, children, adolescents, and adults.
B. Identify specific intervention strategies that address the needs of individuals in high-risk groups including, but not limited to, infants born to HBsAg-positive mothers, clients engaged in injection drug use (IDU)/substance abuse, clients in STD/HIV clinics, men who have sex with men, homeless populations, and inmates in correctional settings.
C. Identify specific intervention strategies that address the viral hepatitis prevention needs of individuals in groups with health disparities including, but not limited to, Asian Americans and Pacific Islanders, American Indians/Alaska Natives, and African-Americans.
D. Describe methods for integrating and evaluating viral hepatitis prevention services into existing programs.
E. Identify and access communication, education, and training needs and available resources for viral hepatitis prevention and control; evaluate the effectiveness of education and training methods.
| |||
| Moderators: | T. Stephen Jones Miriam Alter | ||
| 8:30 AM | Epidemiologic Update: Hepatitis C - Miriam Alter, DVH, CDC | ||
| 8:50 AM | Framing the Issues: Reflections on Epi, Science, Program and the Future of Viral Hepatitis Prevention for IDU - T. Stephen Jones | ||
| 9:10 AM | Hepatitis Prevention for IDU: What Do We Know? - David Vlahov, Director, Center for Urban Epidemiologic Studies, New York Academy of Medicine | ||
| 9:30 AM | What Should We Be Doing? Designing and Implementing a Comprehensive Hepatitis Prevention Strategy for IDU - Guthrie Birkhead, Director, NY State AIDS Institute | ||
The 2005 National Viral Hepatitis Prevention Conference of CDC